Editorial: Prediabetes: new insights on the diagnosis, risk stratification, comorbidites, cardiovascular disease, microvascular complications, and treatment.
(2023) Frontiers in Endocrinology — Vol. 14, p. 1214479 [1-3] (2023)
Files
2023_Neves_Front_Endocrinol.pdf
Open Access - Adobe PDF
- 740.07 KB
Details
- Authors
- Abstract
- Prediabetes is a highly prevalent condition affecting more than one-third of adults in the US and more than one-fifth in Europe. In addition to the well-known increased risk of progression to diabetes, prediabetes is also associated with an increased risk of cardiovascular complications. The focus on mechanisms and interventions to reduce the risk of cardio-renal complications in prediabetes is markedly less than that on preventing diabetes. More research is needed to better characterize new markers of microvascular and macrovascular risk in prediabetes and to develop new interventions to minimize this risk. In the Research Topic “Prediabetes: New Insights on Diagnosis, Risk Stratification, Comorbidities, Cardiovascular Disease, Microvascular Complications, and Treatment” the authors have made significant contributions to the field of prediabetes (Shu et al., Wang et al., Cloro et al., Wang et al., Zhu et al., Wang et al.)
- Affiliations
Citations
Neves, J. S., Buysschaert, M., & Bergman, M. (2023). Editorial: Prediabetes: new insights on the diagnosis, risk stratification, comorbidites, cardiovascular disease, microvascular complications, and treatment. Frontiers in Endocrinology, 14, 1214479 [1-3]. https://doi.org/10.3389/fendo.2023.1214479 (Original work published 2023)